BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22285763)

  • 41. A proposal for a novel staging system in renal pelvicaliceal urothelial carcinomas.
    Cho KS; Cho DS; Choi YD; Hong SJ; Kim SJ; Cho NH
    Hum Pathol; 2007 Nov; 38(11):1639-48. PubMed ID: 17651786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study.
    Tanaka N; Kikuchi E; Shirotake S; Kanao K; Matsumoto K; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Ito Y; Kosaka T; Kodaira K; Oyama M; Miyajima A; Momma T; Nakagawa K; Ueno M; Oya M
    Eur Urol; 2014 Jan; 65(1):227-34. PubMed ID: 23219372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peripelvic/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma.
    Park J; Park S; Song C; Hong JH; Kim CS; Ahn H
    World J Urol; 2014 Feb; 32(1):157-63. PubMed ID: 23568447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
    Capitanio U; Shariat SF; Isbarn H; Weizer A; Remzi M; Roscigno M; Kikuchi E; Raman JD; Bolenz C; Bensalah K; Koppie TM; Kassouf W; Fernández MI; Ströbel P; Wheat J; Zigeuner R; Langner C; Waldert M; Oya M; Guo CC; Ng C; Montorsi F; Wood CG; Margulis V; Karakiewicz PI
    Eur Urol; 2009 Jul; 56(1):1-9. PubMed ID: 19361911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes.
    Rink M; Xylinas E; Trinh QD; Lotan Y; Margulis V; Raman JD; Fisch M; Lee RK; Chun FK; Abdennabi J; Seitz C; Pycha A; Zlotta AR; Karakiewicz PI; Babjuk M; Scherr DS; Shariat SF;
    BJU Int; 2013 Sep; 112(5):623-37. PubMed ID: 23465088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients.
    Remzi M; Haitel A; Margulis V; Karakiewicz P; Montorsi F; Kikuchi E; Zigeuner R; Weizer A; Bolenz C; Bensalah K; Suardi N; Raman JD; Lotan Y; Waldert M; Ng CK; Fernández M; Koppie TM; Ströbel P; Kabbani W; Murai M; Langner C; Roscigno M; Wheat J; Guo CC; Wood CG; Shariat SF
    BJU Int; 2009 Feb; 103(3):307-11. PubMed ID: 18990163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density.
    Bolenz C; Shariat SF; Fernández MI; Margulis V; Lotan Y; Karakiewicz P; Remzi M; Kikuchi E; Zigeuner R; Weizer A; Montorsi F; Bensalah K; Wood CG; Roscigno M; Langner C; Koppie TM; Raman JD; Mikami S; Michel MS; Ströbel P
    BJU Int; 2009 Feb; 103(3):302-6. PubMed ID: 18990164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.
    Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Taguchi S; Tabata M; Kaneko T; Ishikawa A; Miyazaki H; Kondo Y; Matsumoto A; Naito A; Hikatsu M; Fujii Y; Akiyama Y; Yamada Y; Sato Y; Nomiya A; Yamada D; Murata T; Suzuki M; Enomoto Y; Nishimatsu H; Takeuchi T; Tanaka Y; Kume H
    World J Urol; 2023 Mar; 41(3):767-776. PubMed ID: 36739339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.
    Zarei S; Frank I; Boorjian SA; Thompson RH; Kim S; Weight C; Tarrell R; Thapa P; Cheville JC
    J Urol; 2012 Nov; 188(5):1706-11. PubMed ID: 22998911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
    Raman JD; Ng CK; Scherr DS; Margulis V; Lotan Y; Bensalah K; Patard JJ; Kikuchi E; Montorsi F; Zigeuner R; Weizer A; Bolenz C; Koppie TM; Isbarn H; Jeldres C; Kabbani W; Remzi M; Waldert M; Wood CG; Roscigno M; Oya M; Langner C; Wolf JS; Ströbel P; Fernández M; Karakiewcz P; Shariat SF
    Eur Urol; 2010 Jun; 57(6):1072-9. PubMed ID: 19619934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Aziz A; Rink M; Gakis G; Kluth LA; Dechet C; Miller F; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Fisch M; Burger M; Fritsche HM
    Urol Int; 2014; 93(3):352-60. PubMed ID: 25138778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathological prognostic indicators in renal cell carcinoma].
    Rey Rey J; León Ramírez D; López García S; Fernández Vázquez P; Benavente Delgado J; Ojea Calvo A
    Actas Urol Esp; 2010 Jan; 34(1):71-7. PubMed ID: 20223135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
    Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Kabbani W; Langner C; Guo CC; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
    BJU Int; 2011 Oct; 108(8):1286-91. PubMed ID: 21332905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study.
    Berod AA; Colin P; Yates DR; Ouzzane A; Audouin M; Adam E; Arroua F; Marchand C; Bigot P; Soulié M; Roumiguié M; Polguer T; Gardic S; Grès P; Ravier E; Neuzillet Y; Delage F; Bodin T; Pignot G; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt C):E1035-40. PubMed ID: 22568669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Kamihira O; Hattori R; Yamaguchi A; Kawa G; Ogawa O; Habuchi T; Kawauchi A; Uozumi J; Yokoi S; Tsujihata M; Hasui Y; Miyakoda K; Tada H; Ono Y; Naito S
    Eur Urol; 2009 Jun; 55(6):1397-407. PubMed ID: 19299072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications.
    Neuzillet Y; Lebret T; Molinie V; Yonneau L; Herve JM; Theodore C; Botto H
    BJU Int; 2012 Dec; 110(11):1736-41. PubMed ID: 22998125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.